ClinicalTrials.govpublic full text
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
laryngeal cancer, hypopharynx cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 249579
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.